Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development (Q37781050)
scientific article published on September 2010
Language:
(P31) (Q13442814)
(P50) (Q66370852)
(Q66370920)
(P304) 713-721
(P407) (Q1860)
(P433) 5
(P478) 9
(P577) Wednesday, September 1, 2010
(P921) (Q27139135)
(Q419940)
(P1433) (Q5421206)
(P1476) "Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development" (language: en)
(P2860) (Q34268535)
(Q35621355)
(Q34657509)
(Q33700942)
(Q37283128)
(Q35844144)
(Q35184329)
(Q29547900)
(Q35993288)
(Q37411307)
(Q36988579)
(Q37022464)
(Q36584216)
(Q54703960)
(Q33518153)
(Q44353700)
(Q51996142)
(Q46470629)
(Q37063600)
(Q36802620)
(Q37044749)
(Q37431597)
(Q37498272)
(Q37068545)
(Q37642276)
(Q33379225)
(Q33384955)
(Q33384766)
(Q34596305)
(Q33379934)
(Q46047569)
(Q37452843)
(Q42538832)
(Q34289635)
(Q33387517)
(Q46709661)
(Q46084072)
(Q56996659)
(Q57731587)
(Q58023949)
other details
description scientific article published on September 2010

External Links